784872007: Product containing precisely physostigmine salicylate 5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product\...

\Medicinal product categorised by disposition\Acetylcholine receptor agonist-containing product\Muscarinic receptor agonist-containing product\Pilocarpine-containing product\Pilocarpine-containing product in ocular dose form\Physostigmine- and pilocarpine-containing product in ocular dose form\Physostigmine and pilocarpine only product in ocular dose form\Physostigmine salicylate 5 mg/mL and pilocarpine hydrochloride 40 mg/mL eye solution
\Medicinal product categorised by disposition\Acetylcholine receptor agonist-containing product\Muscarinic receptor agonist-containing product\Pilocarpine-containing product\Physostigmine- and pilocarpine-containing product\Physostigmine- and pilocarpine-containing product in ocular dose form\Physostigmine and pilocarpine only product in ocular dose form\Physostigmine salicylate 5 mg/mL and pilocarpine hydrochloride 40 mg/mL eye solution
\Medicinal product categorised by disposition\Acetylcholine receptor agonist-containing product\Muscarinic receptor agonist-containing product\Pilocarpine-containing product\Physostigmine- and pilocarpine-containing product\Physostigmine and pilocarpine only product\Physostigmine and pilocarpine only product in ocular dose form\Physostigmine salicylate 5 mg/mL and pilocarpine hydrochloride 40 mg/mL eye solution
\Medicinal product categorised by disposition\Enzyme inhibitor-containing product\Acetylcholinesterase inhibitor-containing product\Reversible anticholinesterase-containing product\Physostigmine-containing product\Physostigmine-containing product in ocular dose form\Physostigmine- and pilocarpine-containing product in ocular dose form\Physostigmine and pilocarpine only product in ocular dose form\Physostigmine salicylate 5 mg/mL and pilocarpine hydrochloride 40 mg/mL eye solution
\Medicinal product categorised by disposition\Enzyme inhibitor-containing product\Acetylcholinesterase inhibitor-containing product\Reversible anticholinesterase-containing product\Physostigmine-containing product\Physostigmine- and pilocarpine-containing product\Physostigmine- and pilocarpine-containing product in ocular dose form\Physostigmine and pilocarpine only product in ocular dose form\Physostigmine salicylate 5 mg/mL and pilocarpine hydrochloride 40 mg/mL eye solution
\Medicinal product categorised by disposition\Enzyme inhibitor-containing product\Acetylcholinesterase inhibitor-containing product\Reversible anticholinesterase-containing product\Physostigmine-containing product\Physostigmine- and pilocarpine-containing product\Physostigmine and pilocarpine only product\Physostigmine and pilocarpine only product in ocular dose form\Physostigmine salicylate 5 mg/mL and pilocarpine hydrochloride 40 mg/mL eye solution

\Medicinal product categorised by structure\Organic acid and/or organic acid derivative-containing product\Carboxylic acid and/or carboxylic acid derivative-containing product\Carbamate-containing product\Physostigmine-containing product\Physostigmine-containing product in ocular dose form\Physostigmine- and pilocarpine-containing product in ocular dose form\Physostigmine and pilocarpine only product in ocular dose form\Physostigmine salicylate 5 mg/mL and pilocarpine hydrochloride 40 mg/mL eye solution
\Medicinal product categorised by structure\Organic acid and/or organic acid derivative-containing product\Carboxylic acid and/or carboxylic acid derivative-containing product\Carbamate-containing product\Physostigmine-containing product\Physostigmine- and pilocarpine-containing product\Physostigmine- and pilocarpine-containing product in ocular dose form\Physostigmine and pilocarpine only product in ocular dose form\Physostigmine salicylate 5 mg/mL and pilocarpine hydrochloride 40 mg/mL eye solution
\Medicinal product categorised by structure\Organic acid and/or organic acid derivative-containing product\Carboxylic acid and/or carboxylic acid derivative-containing product\Carbamate-containing product\Physostigmine-containing product\Physostigmine- and pilocarpine-containing product\Physostigmine and pilocarpine only product\Physostigmine and pilocarpine only product in ocular dose form\Physostigmine salicylate 5 mg/mL and pilocarpine hydrochloride 40 mg/mL eye solution
\Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Azole-containing product\Imidazole-containing product\Pilocarpine-containing product\Pilocarpine-containing product in ocular dose form\Physostigmine- and pilocarpine-containing product in ocular dose form\Physostigmine and pilocarpine only product in ocular dose form\Physostigmine salicylate 5 mg/mL and pilocarpine hydrochloride 40 mg/mL eye solution
\Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Azole-containing product\Imidazole-containing product\Pilocarpine-containing product\Physostigmine- and pilocarpine-containing product\Physostigmine- and pilocarpine-containing product in ocular dose form\Physostigmine and pilocarpine only product in ocular dose form\Physostigmine salicylate 5 mg/mL and pilocarpine hydrochloride 40 mg/mL eye solution
\Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Azole-containing product\Imidazole-containing product\Pilocarpine-containing product\Physostigmine- and pilocarpine-containing product\Physostigmine and pilocarpine only product\Physostigmine and pilocarpine only product in ocular dose form\Physostigmine salicylate 5 mg/mL and pilocarpine hydrochloride 40 mg/mL eye solution

\Medicinal product categorised by therapeutic role\Antiglaucoma agent\...

\Pilocarpine-containing product in ocular dose form\Physostigmine- and pilocarpine-containing product in ocular dose form\Physostigmine and pilocarpine only product in ocular dose form\Physostigmine salicylate 5 mg/mL and pilocarpine hydrochloride 40 mg/mL eye solution

\Physostigmine-containing product in ocular dose form\Physostigmine- and pilocarpine-containing product in ocular dose form\Physostigmine and pilocarpine only product in ocular dose form\Physostigmine salicylate 5 mg/mL and pilocarpine hydrochloride 40 mg/mL eye solution

\Product manufactured as ocular dose form\Pilocarpine-containing product in ocular dose form\Physostigmine- and pilocarpine-containing product in ocular dose form\Physostigmine and pilocarpine only product in ocular dose form\Physostigmine salicylate 5 mg/mL and pilocarpine hydrochloride 40 mg/mL eye solution
\Product manufactured as ocular dose form\Physostigmine-containing product in ocular dose form\Physostigmine- and pilocarpine-containing product in ocular dose form\Physostigmine and pilocarpine only product in ocular dose form\Physostigmine salicylate 5 mg/mL and pilocarpine hydrochloride 40 mg/mL eye solution

\Autonomic agent\Parasympathomimetic agent-containing product\...

\Acetylcholinesterase inhibitor-containing product\Reversible anticholinesterase-containing product\Physostigmine-containing product\...

\Physostigmine-containing product in ocular dose form\Physostigmine- and pilocarpine-containing product in ocular dose form\Physostigmine and pilocarpine only product in ocular dose form\Physostigmine salicylate 5 mg/mL and pilocarpine hydrochloride 40 mg/mL eye solution

\Physostigmine- and pilocarpine-containing product\Physostigmine- and pilocarpine-containing product in ocular dose form\Physostigmine and pilocarpine only product in ocular dose form\Physostigmine salicylate 5 mg/mL and pilocarpine hydrochloride 40 mg/mL eye solution
\Physostigmine- and pilocarpine-containing product\Physostigmine and pilocarpine only product\Physostigmine and pilocarpine only product in ocular dose form\Physostigmine salicylate 5 mg/mL and pilocarpine hydrochloride 40 mg/mL eye solution

\Acetylcholine receptor agonist-containing product\Muscarinic receptor agonist-containing product\Pilocarpine-containing product\...

\Pilocarpine-containing product in ocular dose form\Physostigmine- and pilocarpine-containing product in ocular dose form\Physostigmine and pilocarpine only product in ocular dose form\Physostigmine salicylate 5 mg/mL and pilocarpine hydrochloride 40 mg/mL eye solution

\Physostigmine- and pilocarpine-containing product\Physostigmine- and pilocarpine-containing product in ocular dose form\Physostigmine and pilocarpine only product in ocular dose form\Physostigmine salicylate 5 mg/mL and pilocarpine hydrochloride 40 mg/mL eye solution
\Physostigmine- and pilocarpine-containing product\Physostigmine and pilocarpine only product\Physostigmine and pilocarpine only product in ocular dose form\Physostigmine salicylate 5 mg/mL and pilocarpine hydrochloride 40 mg/mL eye solution

Status: current, Defined. Date: 31-Jul 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3765651015 Product containing precisely physostigmine salicylate 5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug) en Fully specified name Active Case insensitive SNOMED CT core

3765652010 Physostigmine salicylate 5 mg/mL and pilocarpine hydrochloride 40 mg/mL eye solution en Synonym Active Initial character case insensitive SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Physostigmine salicylate 5 mg/mL and pilocarpine hydrochloride 40 mg/mL eye solution	Plays role	Antiglaucoma therapeutic role	true	Inferred relationship	Some
Physostigmine salicylate 5 mg/mL and pilocarpine hydrochloride 40 mg/mL eye solution	Has concentration strength denominator unit	mL	true	Inferred relationship	Some	1
Physostigmine salicylate 5 mg/mL and pilocarpine hydrochloride 40 mg/mL eye solution	Has concentration strength numerator unit	mg	true	Inferred relationship	Some	1
Physostigmine salicylate 5 mg/mL and pilocarpine hydrochloride 40 mg/mL eye solution	Has concentration strength denominator value	1	false	Inferred relationship	Some	1
Physostigmine salicylate 5 mg/mL and pilocarpine hydrochloride 40 mg/mL eye solution	Has concentration strength denominator unit	mL	true	Inferred relationship	Some	2
Physostigmine salicylate 5 mg/mL and pilocarpine hydrochloride 40 mg/mL eye solution	Count of base of active ingredient	2	false	Inferred relationship	Some
Physostigmine salicylate 5 mg/mL and pilocarpine hydrochloride 40 mg/mL eye solution	Has concentration strength numerator unit	mg	true	Inferred relationship	Some	2
Physostigmine salicylate 5 mg/mL and pilocarpine hydrochloride 40 mg/mL eye solution	Has concentration strength denominator value	1	false	Inferred relationship	Some	2
Physostigmine salicylate 5 mg/mL and pilocarpine hydrochloride 40 mg/mL eye solution	Has manufactured dose form	Eye solution	true	Inferred relationship	Some
Physostigmine salicylate 5 mg/mL and pilocarpine hydrochloride 40 mg/mL eye solution	Is a	Physostigmine and pilocarpine only product in ocular dose form	true	Inferred relationship	Some
Physostigmine salicylate 5 mg/mL and pilocarpine hydrochloride 40 mg/mL eye solution	Has precise active ingredient	Pilocarpine hydrochloride	true	Inferred relationship	Some	1
Physostigmine salicylate 5 mg/mL and pilocarpine hydrochloride 40 mg/mL eye solution	Has BoSS	Physostigmine salicylate	true	Inferred relationship	Some	2
Physostigmine salicylate 5 mg/mL and pilocarpine hydrochloride 40 mg/mL eye solution	Has BoSS	Pilocarpine hydrochloride	true	Inferred relationship	Some	1
Physostigmine salicylate 5 mg/mL and pilocarpine hydrochloride 40 mg/mL eye solution	Has concentration strength numerator value	5	false	Inferred relationship	Some	2
Physostigmine salicylate 5 mg/mL and pilocarpine hydrochloride 40 mg/mL eye solution	Has concentration strength numerator value	40	false	Inferred relationship	Some	1
Physostigmine salicylate 5 mg/mL and pilocarpine hydrochloride 40 mg/mL eye solution	Has precise active ingredient	Physostigmine salicylate	true	Inferred relationship	Some	2

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

Reference Sets

Description inactivation indicator reference set

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3765651015	Product containing precisely physostigmine salicylate 5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug)	en	Fully specified name	Active	Case insensitive	SNOMED CT core
3765652010	Physostigmine salicylate 5 mg/mL and pilocarpine hydrochloride 40 mg/mL eye solution	en	Synonym	Active	Initial character case insensitive	SNOMED CT core